is the tirzepatide shortage over FDA says after taking a second look Drugmakers battle pharmacies over compounded

New research has lent weight to the intriguing idea that GLP-1 agonists may help people with substance use disorders break their addiction.

Learn common reasons for stalled results and practical tips to restart progress with diet, activity, and clinical guidance.

Women on hormone therapy saw 30% more weight loss with semaglutide compared to those not on hormone therapy

Perfect For: Patients focused on weight management support

GLP-1 weight-loss drugs pose hidden risks for young women Women taking popular weight-loss medications during their reproductive years may be unaware of associated risks to pregnancy and unborn babies, warn Flinders University researchers

Stay informed about your health and appearance.